Pharmaceutical Stocks

Pharmaceutical stocks have grown tremendously as medicine advances. With diseases like diabetes and even Ebola affecting more and more of the population, pharmaceutical companies are racing to find cures – further  advancing medicine and driving their stock prices up. Corporations like Pfizer (NYSE:PFE) and Gilead Sciences (NASDAQ:GILD) are leading the charge against disease but smaller companies such as Myland (NASDAQ:MYL) are interesting investments as well.

Recent Articles

Trade of the Day: Pfizer (PFE)

PFE is bouncing off support -- and, as a perennial powerhouse, we expect the stock to move back up toward its recent highs. More 

4 Cheap Pharma Stocks for Quick Profits

For investors who rely on technical signals, these four cheap pharma stocks are showing signs of moving up in the next few days. Buy these pharma stocks now to net profits. More 

3 Best-of-Breed Small Caps: Biotech Stocks to Buy

These three small-cap biotech stocks have a bright future and the ability to create advantages in the market. More 

Investing in Alzheimer’s Disease Drugs Just Became Complicated

Everything pharmaceutical companies thought they knew about Alzheimer's disease may (or may not) be wrong. More 

Trade of the Day: Rigel Pharmaceuticals (RIGL)

I'm still focusing on bullish trades given that stock market support levels have held. More 

Valeant Shareholders May Lose in the Salix ‘Win’ (VRX, SLXP, ENDP)

Valeant Pharmaceuticals (VRX) swiped Salix Pharmaceuticals (SLXP) from Endo International (ENDP), but was it really worth it? More 

Trade of the Day: Merck (MRK)

With major U.S. stock indexes returning to bullish trends, today's trade is a call option in "Big Pharma" stock Merck (MRK). More 

Great Biotech Stocks for Retirement Investors

Yes, Biotech stocks DO belong in your retirement portfolio. Here are three ways to add them and reap the rewards. More 

Pfizer, Merck Stock – Same Ol’ Slumping Revenues, Same Mixed Prospects

The loss of exclusivity on blockbuster drugs continued to weigh in the top line at both Pfizer and Merck in the most recent quarter. More 

Inovio Pharmaceuticals Announces 1-4 Reverse Split for INO Stock

Inovio Pharmaceuticals said that its shareholders had voted to approve a 1-for-4 reverse stock split. INO stock fell more than 5%. More